Roche lifts 2019 sales view again as Chinese demand soars

ZURICH (Reuters) - Swiss drugmaker Roche lifted its 2019 sales target on Wednesday for the third time this year, helped by newer medicines and as China bought more cancer drugs to treat a disease blamed for a quarter of the nation's annual deaths.Roche's full-year revenue is now seen growing at a high-single-digit percentage rate, the Basel-based company said, to what would easily top $60 billion. That is up from the July's mid- to high-single digit growth estimate. The new forecast sets a high..